ASEAN

JAKARTA, WARTA-APOTEKER.com – ASEAN-Japan Pharmaceuticals Training in Risk Management Plan  (RMP) 2023 is a collaboration program conducted by The Indonesian FDA, Pharmaceuticals and Medical Devices  Agency (PMDA, Japan), and Universitas Indonesia (UI) with the support of the Japan-ASEAN Integration Fund  (JAIF). This project aims to advance regulatory harmonization activities concerning drug products among the ASEAN  Member States. The program consists of…